Elastomeric Closure: Definition and Role in Injectable Packaging
An elastomeric closure is the rubber (elastomer) component that seals a pharmaceutical container, most commonly the vial stopper that a needle pierces and that reseals after the needle is withdrawn. It is the part of the container closure system that forms the resealable barrier between the sterile drug and the outside environment. In a vial, the elastomeric closure works with the aluminium or aluminium-plastic seal crimped over it: the rubber provides the seal, the metal holds it under compression.
This page defines an elastomeric closure, explains what it is made from, describes its function, and outlines the standards that govern its material and performance.
Key takeaways
- An elastomeric closure is the moulded rubber component (the vial stopper, plus the rubber in cartridges and prefilled-syringe systems) that seals a container and reseals after needle penetration.
- It is the resealable barrier in the container closure system; the seal crimped over it holds it in compression.
- Stoppers are usually moulded from butyl or halobutyl rubber for low gas and moisture permeability.
- The material requirements sit under USP <381>; functional suitability (penetrability, self-sealing) under USP <382>.
- Dimensions and requirements for closures for injection vials are covered by ISO 8362-2, with freeze-drying closures under ISO 8362-5.
- What can migrate from the rubber into the drug is controlled through extractables and leachables studies.
What is an elastomeric closure?
An elastomeric closure is a closure made from an elastomer, a rubber-like polymer that deforms under load and springs back, used to seal pharmaceutical containers so a needle can pass through and the container reseals afterwards. The most familiar example is the grey rubber stopper in an injectable vial, but the term also covers the rubber components in cartridges, prefilled syringes, and similar parenteral delivery systems.
The defining property is elasticity. Because the material is soft and recovers its shape, a needle can pierce it to withdraw or deliver the drug, and when the needle is removed the rubber closes the hole behind it. That self-sealing behaviour is what makes multiple-dose vials possible and what keeps single-dose vials sealed until the moment of use. USP refers to these parts as elastomeric components, and they are evaluated both for what they are made of and for how they perform.
What an elastomeric closure is made of
Elastomeric closures are moulded from synthetic rubber compounds, most commonly butyl or halobutyl (bromobutyl and chlorobutyl) rubber, chosen for low permeability to gases and moisture. The compound is more than the base polymer: it is a formulation that includes fillers, curing (vulcanising) agents, and other additives that give the finished stopper its hardness, resilience, and sealing behaviour.
- Butyl rubber is the workhorse base polymer for vial stoppers because it has a very low permeability to oxygen and water vapour, which protects sensitive drugs. See butyl rubber stopper for detail.
- Halobutyl rubbers (bromobutyl and chlorobutyl) add halogen to the butyl backbone, improving cure characteristics and chemical compatibility.
- Coatings and laminates (for example fluoropolymer films) are sometimes applied to the surface that contacts the drug to further reduce extractables and improve machinability.
Because the closure contacts the drug product directly, the choice of compound is driven by compatibility with the specific formulation as much as by the mechanical requirements.
The function of an elastomeric closure
An elastomeric closure has to do two opposing things: form a tight, lasting seal, and still let a needle through and reseal afterwards. Its functional jobs are:
- Sealing. Seated in the vial mouth and compressed by the crimped seal, the stopper’s sealing surfaces press against the glass to keep the contents sterile and protected.
- Penetrability. A hypodermic needle must pierce the stopper with a predictable, moderate force, without the stopper dislodging or the needle bending.
- Self-sealing (resealing). After the needle is withdrawn, the rubber closes the puncture so the container does not leak, which matters most for multiple-dose presentations.
- Resistance to fragmentation (coring). The closure should not shed loose rubber fragments into the drug when pierced.
These functional attributes are evaluated under USP <382>, which addresses how the component performs in its assembled system rather than what it is made of.
Standards for elastomeric closures
Elastomeric closures are qualified on two fronts: material requirements and functional suitability. A closure is not fully characterised by one alone.
| Aspect | Standard | What it covers |
|---|---|---|
| Material requirements | USP <381> | Physicochemical requirements of the elastomeric material |
| Functional suitability | USP <382> | Penetrability, self-sealing, package-integrity contribution |
| Dimensions and requirements | ISO 8362-2 | Closures for injection vials |
| Freeze-drying closures | ISO 8362-5 | Slotted closures for lyophilisation |
| Migration into the drug | Extractables and leachables | What can migrate from the rubber into the product |
In practice a drug manufacturer qualifying a stopper looks at the material (USP <381>), the function (USP <382>), the dimensional standard (ISO 8362-2), and extractables and leachables work for the specific formulation. The European Pharmacopoeia carries parallel requirements for rubber closures for containers for aqueous parenteral preparations.
How this works in practice at Autofits
The elastomeric closure forms the resealable barrier; Autofits manufactures the aluminium and aluminium-plastic seals that crimp over it to hold it in place. The range includes FlipTop Optima flip-off seals, tear-off and tear-down aluminium seals, and aluminium pilfer-proof (ROPP) caps, in 13, 20, and 32 mm sizes (see the full products page). The seal compresses the rubber stopper against the glass so the closure can maintain its seal between needle penetrations. Autofits produces these seals under an ISO 15378:2017 quality system, alongside ISO 9001:2015 and ISO 14001:2015 certification and a Drug Master File, in a 75,000 sq ft Nashik facility with an ISO Class 8 cleanroom and high-speed visual inspection. The full certification set is on the quality page.
Frequently asked questions
What is an elastomeric closure?
An elastomeric closure is the rubber component that seals a pharmaceutical container and reseals after a needle is withdrawn. The most common example is the vial stopper, but the term also covers the rubber in cartridges and prefilled syringes. It forms the resealable barrier in the container closure system, while the metal seal crimped over it holds it under compression against the glass.
What is an elastomeric closure made of?
Elastomeric closures are moulded from synthetic rubber compounds, most often butyl or halobutyl (bromobutyl, chlorobutyl) rubber, selected for low permeability to oxygen and moisture. The compound also contains fillers, curing agents, and additives, and the drug-contact surface is sometimes coated or laminated with a fluoropolymer film to reduce extractables.
What is the difference between an elastomeric closure and a vial seal?
The elastomeric closure is the rubber stopper that forms the seal and lets a needle through. The vial seal is the aluminium or aluminium-plastic cap crimped over the stopper to hold it down against the glass. The stopper creates the barrier; the seal keeps that barrier under compression and provides tamper evidence.
What standards apply to elastomeric closures?
The material requirements of an elastomeric closure are covered by USP <381>, and its functional suitability (penetrability, self-sealing) by USP <382>. Dimensions and requirements for closures for injection vials are in ISO 8362-2, and freeze-drying closures in ISO 8362-5. What can migrate from the rubber into the drug is studied through extractables and leachables testing.
Why are vial stoppers usually grey?
Vial stoppers are commonly grey because of the carbon and mineral fillers and the rubber compound used, though stoppers are also produced in other colours. Colour can be used to differentiate closure types or formulations, but it is the rubber compound and its qualification, not the colour, that determine sealing and compatibility.
Related reading
- Butyl rubber stopper: definition
- Vial closure: definition and components
- USP <381>: elastomeric components in injectable packaging
- USP <382>: elastomeric component functional suitability
- Extractables and leachables in vial closures
Sources
- USP-NF: General Chapter <381>, Elastomeric Components in Injectable Pharmaceutical Product Packaging/Delivery Systems (https://www.usp.org/)
- USP-NF: General Chapter <382>, Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems (https://www.usp.org/)
- ISO: ISO 8362-2:2024, Injection containers and accessories, Part 2: Closures for injection vials (https://www.iso.org/standard/87251.html)
- ISO: ISO 8362-5:2016, Injection containers and accessories, Part 5: Freeze drying closures for injection vials (https://www.iso.org/standard/65448.html)
*Last updated: 2026-06-18. This article is general technical information, not regulatory or compliance advice; confirm current standard editions and requirements with the issuing bodies.*
